Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
kr-9.66 Mil
% of Total Estimate Gain
-10.42%

RBC Global Opportunities Fund's Novo Nordisk AS Holding Summary

As of 2025-03-31, RBC FUNDS TRUST held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and RBC FUNDS TRUST now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2023Q4. And since then RBC Global Opportunities Fund has made 1 purchases of OCSE:NOVO B, at an average price of kr684.25, for a total of 135,503.00 shares. In addition, there have been 5 sales at an average price of kr612.93 for 135,503.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr447.05, RBC Global Opportunities Fund's estimated gain on his OCSE:NOVO B holdings is kr-9.66 Mil, reflecting a -10.42% gain to date.

RBC Global Opportunities Fund OCSE:NOVO B (kr447.05) Holding Chart

RBC Global Opportunities Fund OCSE:NOVO B (kr447.05) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1